Skip to main content
INSW
NYSE Energy & Transportation

Shareholders Ratify Poison Pill and Approve Executive Compensation Increases

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Oil & Gas Stocks · Energy
Sentiment info
Neutral
Importance info
7
Price
$82.01
Mkt Cap
$4.06B
52W Low
$36.03
52W High
$92.66
52W Position info
128% above low
Off High info
11% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

INSW has more than doubled off its 52-week low of $36.03.

Summary

International Seaways shareholders ratified the company's shareholder rights plan and approved increased compensation for executives and directors at the Annual Meeting.


Key Events · Corporate Governance and Compliance · INSW

  • Shareholder Rights Plan Ratified

    Shareholders approved the Second Amended and Restated Rights Agreement, a defensive measure against hostile takeovers, which was initially announced on April 9, 2026. The resolution passed with 27,238,846 votes in favor and 14,456,177 against.

  • Executive Compensation Increases Approved

    The Board approved base salary increases for the CEO (to $850,000), CFO (to $675,000), CAO (to $600,000), and other senior VPs (to $500,000 each), retroactive to January 1, 2026. Equity target opportunities for several executives were also increased.

  • Director Compensation Adjusted

    Annual cash compensation for the Chair of the Board was increased to $190,000, retroactive to March 10, 2026. Equity compensation in the form of restricted stock grants was provided for non-employee directors, including $235,000 for the non-Executive Chairman and $150,000 for other non-employee directors.

  • Routine Annual Meeting Approvals

    Shareholders re-elected all nine directors, ratified Ernst & Young LLP as the independent registered public accounting firm for 2026, and approved executive compensation in an advisory vote.


Analysis · INSW · Energy & Transportation

This 8-K details the outcomes of the Annual Meeting, including the ratification of a shareholder rights plan (poison pill) which was previously announced. While the initial announcement of the poison pill was a significant governance event, its ratification confirms the company's defensive stance against potential hostile takeovers. Additionally, the board approved salary and equity target increases for key executives and directors, reflecting adjustments to compensation following a period of strong financial performance.

At the time of this filing, INSW was trading at $82.01 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $36.03 to $92.66. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INSW - Latest Insights

INSW
May 12, 2026, 4:13 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $88.40
Real-time Price: $91.13 info
Change: +$2.73 (+3%) info
Market Cap: $4.634B info
INSW
May 12, 2026, 4:07 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $88.40
Real-time Price: $91.13 info
Change: +$2.73 (+3%) info
Market Cap: $4.634B info
INSW
May 11, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $88.00
Real-time Price: $91.13 info
Change: +$3.13 (+4%) info
Market Cap: $4.634B info
INSW
May 11, 2026, 5:08 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $88.00
Real-time Price: $91.13 info
Change: +$3.13 (+4%) info
Market Cap: $4.634B info
INSW
May 11, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $89.71
Real-time Price: $91.13 info
Change: +$1.42 (+2%) info
Market Cap: $4.634B info